DR. LAL Path Labs Ltd.
NSE: LALPATHLAB · Healthcare Service Provider · sector
₹1,855.60NSE close 2026-10-26
Key numbers
Market cap₹31,100 cr
Price₹1,855.60
52w high / low₹2,039 / ₹1,273
P/E57.2xSector median 22.9x
P/B12.4xSector median 2.0x
Book value₹149.7
Dividend yield0.71%Sector median 0.55%
ROE23.1%Sector median 5.4%
ROCE29.6%Sector median 6.8%
OPM27.9%Sector median 15.9%
Debt / equity0.00xSector median 0.07x
EV/EBITDA36.9xSector median 17.2x
Interest cover30.4x
Current ratio3.48x
Sales growth 3y+11.1%Sector median +13.5%
Profit growth 3y+28.3%Sector median +26.9%
PEG2.04x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹1,332 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 30.4x in the last 12 months.
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 19% of net profit in the last 12 months.
- Dividend paid in 5 of the last 5 financial years.
- Price ₹1,855.60 on 2026-10-26: -9.0% from the 52-week high, +45.8% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹3,572.40 · low ₹1,307.60
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 660 | 597 | 603 | 670 | 731 | 660 | 703 | 798 |
| EBITDA | 202 | 154 | 169 | 192 | 224 | 149 | 187 | 248 |
| OPM % | 30.7% | 25.8% | 28.0% | 28.7% | 30.7% | 22.6% | 26.6% | 31.0% |
| Other income | 22 | 25 | 26 | 28 | 25 | 24 | 24 | 32 |
| Net profit | 129 | 97 | 155 | 132 | 151 | 90 | 131 | 170 |
| EPS (₹) | 7.76 | 5.80 | 9.29 | 7.94 | 9.03 | 5.42 | 7.86 | 10.15 |
| Revenue YoY | +10.7% | +10.6% | +16.6% | +19.1% | ||||
| Profit YoY | +16.6% | -6.4% | -15.2% | +28.0% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 2,087 | 2,017 | 2,227 | 2,461 | 2,763 | 2,891 |
| EBITDA | 561 | 490 | 609 | 696 | 752 | 808 |
| Net profit | 345 | 239 | 358 | 487 | 505 | 542 |
| EPS (₹) | 20.85 | 14.41 | 21.52 | 29.24 | 30.24 | 32.45 |
| Revenue growth | -3.4% | +10.4% | +10.5% | +12.2% | +14.3% | |
| Profit growth | -30.7% | +49.7% | +36.2% | +3.6% | +5.6% | |
| Dividend / share (₹) | 14.00 | 12.00 | 24.00 | 24.00 | 22.50 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +11.1% | +11.8% | +14.3% |
| Net profit | +28.3% | +11.6% | +5.6% |
| EPS | +28.0% | +11.4% | – |
| Share price | – | +5.5% (2y) | +17.1% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 1,666 | 1,849 | 2,173 | 2,508 |
| Borrowings | – | 237 | 83 | 0 | 0 |
| Cash & equivalents | – | 815 | 944 | 1,165 | 1,332 |
| Total assets | – | 2,386 | 2,456 | 2,717 | 3,146 |
| Fixed assets | – | 401 | 343 | 336 | 484 |
| Capital work in progress | – | 3 | 4 | 4 | 6 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 71 | 77 | 88 | 111 |
| Inventory | – | 34 | 37 | 36 | 44 |
| Payables | – | 156 | 187 | 199 | 181 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 447 | 456 | 535 | 569 | 636 |
| Cash from investing | -449 | -287 | -24 | -303 | -422 |
| Cash from financing | 136 | -283 | -414 | -334 | -264 |
| Capex | 476 | 45 | 58 | 54 | 173 |
| Free cash flow | -29 | 411 | 478 | 515 | 462 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 14.3% | 19.3% | 22.4% | 20.1% |
| ROCE % | – | 20.0% | 27.7% | 29.8% | 27.6% |
| Debtor days | – | 13 | 13 | 13 | 15 |
| Inventory days | – | 28 | 30 | 27 | 30 |
| Payable days | – | 127 | 151 | 151 | 123 |
| Cash conversion cycle (days) | – | -86 | -108 | -111 | -78 |
| Working capital days | – | 91 | 108 | 143 | 147 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 52.93% |
| FIIs | 18.73% |
| DIIs | 21.58% |
| of which Mutual funds | 18.68% |
| of which Insurance | 2.46% |
| Government | 0.00% |
| Public (non-institutions) | 6.35% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 53.91% | 53.79% | 53.21% | 53.21% | 53.21% | 53.21% | 53.19% | 52.93% |
| Promoter group | % |
|---|---|
| Arvind Lal | 29.91% |
| Vandana Lal | 19.16% |
| Anjaneya Lal | 2.01% |
| Archana Lal Erdmann | 1.84% |
| Public holders above 1% | % |
|---|---|
| HDFC Mutual Fund - HDFC Nifty Smallcap 250 ETF | 3.91% |
| Smallcap World Fund, INC | 2.60% |
| Uti-flexi CAP Fund | 2.49% |
| Aditya Birla SUN Life Mutual Fund - Aditya Birla SUN Life Small CAP Fund | 2.19% |
| Nippon Life India Trustee Ltd-a/c Nippon India Nifty 500 Equal Weight Index Fund | 2.19% |
| SBI Large & Midcap Fund | 1.49% |
| Life Insurance Corporation Of India | 1.47% |
| Tata India Pharma & Healthcare Fund | 1.39% |
| Invesco International Growth Fund | 1.15% |
1,13,559 shareholders. Pledged: – of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 69.9% | 19.2% | +201.8% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-30 | Dividend | Interim Dividend - Rs 5 Per Share |
| 2026-06-25 | Dividend | Dividend - Rs 4 Per Share |
| 2026-02-05 | Dividend | Interim Dividend - Rs 3.50 Per Share |
| 2025-12-19 | Bonus | Bonus 1:1 |
| 2025-11-07 | Dividend | Interim Dividend - Rs 7 Per Share |
| 2025-08-06 | Dividend | Interim Dividend - Rs 6 Per Share |
| 2025-06-06 | Dividend | Dividend - Rs 6 Per Share |
| 2025-02-05 | Dividend | Interim Dividend - Rs 6 Per Share |
| 2024-11-05 | Dividend | Interim Dividend - Rs 6 Per Share |
| 2024-08-20 | Dividend | Interim Dividend - Rs 6 Per Share |
| 2024-06-10 | Dividend | Dividend - Rs 6 Per Share |
| 2024-02-13 | Dividend | Interim Dividend - Rs 12 Per Share |
| 2023-08-11 | Dividend | Dividend - Rs 6 Per Share |
| 2023-08-11 | Dividend | Interim Dividend - Rs 6 Per Share |
| 2022-08-05 | Dividend | Interim Dividend - Rs 6 Per Share |
| 2022-06-22 | Dividend | Annual General Meeting/Dividend - Rs 6 Per Share |
| 2021-08-18 | Dividend | Interim Dividend - Rs 6 Per Share |
| 2021-07-20 | Dividend | Annual General Meeting/Dividend - Rs 8 Per Share |
| 2021-02-09 | Dividend | Interim Dividend - Rs 6.00 Per Share |
| 2020-11-18 | Dividend | Interim Dividend - Rs 6 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Other Human Health Activities: Activities of Independent Diagnostics/ Pathological Laboratories
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | LALPATHLAB |
| BSE code | 539524 |
| ISIN | INE600L01024 |
| Face value | ₹10.0 |
| Incorporated | 1995-02-14 |
| Website | www.lalpathlabs.com |
| Plants (India / abroad) | 0 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.